Details for New Drug Application (NDA): 011045
✉ Email this page to a colleague
NDA 011045 describes MILPREM-400, which is a drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional details are available on the MILPREM-400 profile page.
The generic ingredient in MILPREM-400 is estrogens, conjugated; meprobamate. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated; meprobamate profile page.
The generic ingredient in MILPREM-400 is estrogens, conjugated; meprobamate. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated; meprobamate profile page.
Summary for 011045
| Tradename: | MILPREM-400 |
| Applicant: | Medpointe Pharm Hlc |
| Ingredient: | estrogens, conjugated; meprobamate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.45MG;400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.45MG;200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
